Skip to main content
News Icon

News categories: Honors & Funding

Successful MIB Future Panel 2025 in Bonn

the MIB Future Panel 2025, organized by the Medical Imaging Center Bonn (MIB) and the Transfer Team of the Medical Faculty Bonn, once again offered an exciting platform for exchange among science, clinics, start-ups, industry, and investors — with a special focus on medical imaging and artificial intelligence (AI).

The highlight was the “Medical Pitch Contest Bonn”, in which ten teams from the Medical Faculty of Bonn presented their ideas to 180 attendees, including prominent investors, competing for prize money totaling €60,000.

“The MIB Future Panel has once again garnered strong resonance this year, both from the pitch teams and the audience. It shows how relevant our thematic focus is and how enriching the exchange on new research approaches is—especially for start-ups and industry,” said Prof. Frank Holz, Director of the Eye Clinic at UKB and founder and spokesperson of the MIB.

AI in Service of Imaging

In the keynote lecture, Prof. Louisa Specht-Riemenschneider, Federal Commissioner for Data Protection and Freedom of Information, emphasized the importance of secure data applications in times of large language models and data networking — a central theme in the panel discussion on using Large Language Models (LLMs) in medicine.

Pitch Competition: Visionary Ideas on Stage

Ten research teams presented their innovative projects in five-minute pitches. The jury, composed of investors from High-Tech Gründerfonds, TechVision Fund, Xlife Sciences, RW.Bank Venture Fund, and V-Bio Ventures, evaluated not only technical feasibility but also commercialization potential and social relevance.

Award winners included:

  • 1st Place (€30,000): ADHD Cycle
    Dr. Alexandra Philipsen, Dr. Marie-Christin Atzor, Rafael Schaider, Victoria Schöffel
    Adapting ADHD treatment for women to account for hormonal changes during the menstrual cycle (Digital Health)
  • 2nd Place (€20,000): CARzi – Tiny Binders, Mighty Fighters
    Dr. Tobias Bald, Carolin Birr, Franziska Schneppenheim
    A biparatopic CAR T-cell product targeting CD155 for treating melanoma and other solid tumors (Therapy)
  • 3rd Place (€10,000): CARe RAiSE Ex-Vivo Assay
    Valentin Schäfer, Dr. Josephine Blersch, Dr. Philip Denner, Dr. Simon Petzinna
    A next-generation diagnostic platform enabling personalized therapy selection in rheumatoid arthritis via a predictive, image-based, ex vivo assay (Diagnostics)

Prof. Bernd Weber, Dean of the Medical Faculty Bonn and acting CEO of UKB, summed up:

“The pitch contest has once again impressively shown with what innovative strength our researchers are shaping the future of medicine. Such formats give progressive ideas a stage and foster interdisciplinary exchange and collaborations, through which research can translate into application.”

Beyond the competition, the panel offered networking opportunities. In the closing session and during the networking lunch, new collaborations between researchers, start-ups, and investor groups were initiated. The MIB Future Panel 2026 is already being planned, with new impulses, workshops, and again a strong pitch competition.

 

Press contact

Daria Siverina

Deputy Press Officer

Department of Communication, University Hospital Bonn

Phone: (+49) 228 287-14416

E-Mail: daria.siverina@ukbonn.de


 

Related news

Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry

Back to the news overview